Navigation Links
World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center
Date:10/8/2008

Facility Design by Leading Architectural Firms

LISBON, Portugal and NEW YORK, Oct. 8 /PRNewswire/ -- Three weeks after awarding two Johns Hopkins University scientists the most prestigious vision award in the world for their research in combating blindness, the Antonio Champalimaud Foundation continued its pioneering work in medical research with the groundbreaking of its 300,000-square-foot research facility. The Champalimaud Foundation Center, named after the late Portuguese businessman and benefactor Antonio Champalimaud, is expected to be not only a cutting edge research facility, but also a magnificent architectural project in a historic section of Lisbon. The center will provide care and research on cancer and neuroscience that will benefit the international medical and scientific community.

By 2030 it is estimated that there will be 20 to 25 million incident cases of cancer around the world, and 13 to 16 million cancer deaths annually. In the US the number of people living with cancer is expected to double from 1.3 to 2.6 million between the years 2000 to 2050, according to the International Agency for Research on Cancer. The Champalimaud Center will attract scientists from all over the world to undertake the most advanced translational research in cancer and neuroscience using a multidisciplinary team approach.

The new center will foster collaboration between world class researchers and renowned cancer specialists. The state-of-the-art facility will foster frontline research in oncology, molecular biology, genetics, immunology, neuroscience and behavior, as well as post-graduate and doctorate programs, and the diagnosis and treatment of neurological and cancer patients.

Signifying the importance of the new center, Portuguese Prime Minister, Jose Socrates, presided, with the Champalimaud Foundation President, Leonor Beleza, over the groundbreaking ceremony. The architect, Charles Correa, addressed the assembly, describing the design of the facility. The ceremony was highlighted by a small robot placing the first stone in the building's foundation. This signified a new and advanced era of scientific exploration and discovery for Portugal. The Center will be built in a historic location, where the Tagus River joins the Atlantic Ocean -- the point from which 15th and 16th -century Portuguese explorers embarked on maritime journeys and discoveries. This location is also symbolic of the new discoveries in the world of science and disease treatment, which are expected to be made at this Center.

Bombay-based firm Charles Correa Associates is the Design Architect, in collaboration with RMJM Hillier as Laboratory and Clinical Design Architects and Consiste of Portugal as the Architect of record. The facility will have Diagnostic, Treatment, and Wellness Centers and an open-air amphitheatre facing the river for public performances. Also, the project will include high-performance buildings that employ optimal energy and resource management. The Champalimaud Center is the first building in a major redevelopment plan to change the face of the Lisbon riverfront. The anticipated inauguration date for the Center is October 5th, 2010.

About the Champalimaud Foundation:

The Champalimaud Foundation supports individual researchers and research teams working at the cutting edge of medical science. It aims to stimulate novel theoretical and practical methodologies by utilizing the experience of both research scientists and medical practitioners, connecting pure scientific investigation with applied clinical research. The Champalimaud Foundation aims to maximize the work being done in the fields of cancer research and neuroscience, including stem cell research and its clinical applications for Parkinson's and Alzheimer's disease, diabetes and spinal injury. It is named for Antonio Champalimaud, who was the richest man in Portugal when he died in 2004, bequeathing a quarter of his $3.1 billion estate to set up the Foundation. See http://www.fchampalimaud.org .

CONTACT:

In the U.S., Richard J. Wolff, rwolff@hfgcg.com, or Mounir Ibrahim, mibrahim@hfgcg.com, +1-646-284-9400

In Europe, Vitor Cunha, +351-9666-19794, vcunha@jlma.pt, all for The Champalimaud Foundation.


'/>"/>
SOURCE The Champalimaud Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Carlson Hotels Worldwide Partners With the American Red Cross in Texas to Provide Relief for Children Affected by Hurricane Ike
2. Many Military Installations Worldwide Participate in National Depression Screening Day
3. Discover a World of Savings with Health Savings Accounts (HSAs)
4. Argentyn 23(R) Homeopathic First Aid Gel - Another Worlds First by Natural-Immunogenics Corp. for Healthcare Professionals
5. Reflex Stock Launches Exciting New Editorial Image Collections to the Worldwide Publishing Industry
6. Scripps Research Institute and IAVI launch worlds first dedicated HIV neutralizing antibody center
7. $9 Million Committed to Bolster Worldwide Measles Initiative
8. HTH Worldwide Welcomes New Chief Financial Officer
9. World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage
10. (Report) World Privacy Forum Publishes Red Flag Rule Suggestions for Hospitals and Providers; New FTC-Enforced Rules Go Into Effect Nov. 1, Can Apply to Health Care Providers
11. New Lottery Ticket Envisions a World Free of MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... , ... The February 13, 2017, assassination of Kim Jong-nam, the half brother ... the deadly use of chemical weapons. Many questions exist about the effect that nerve ... be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of ...
(Date:2/26/2017)... Ireland (PRWEB) , ... February 26, 2017 , ... ... as in 2011 the lab became the world’s first to be ISO/IEC 17025:2005 ... 1 (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... distribution in North America, today announced it would be offering some it’s exclusive ... prides itself on crafting quality and unique baby clothing/feeding products, will team up ...
(Date:2/26/2017)... (PRWEB) , ... February 26, ... ... sets a new technology standard in staffing, scheduling, and reporting for healthcare ... and predict activity throughout the entire staffing process. StaffBridge technology improves staffing ...
(Date:2/26/2017)... Miami, Florida (PRWEB) , ... February 26, 2017 ... ... disease (PD) patients after receiving cognitive rehabilitation, according to a study released today ... already known that cognitive rehabilitation programs are proven to be effective in improving ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... STOCKHOLM , Feb 27, 2017 Period October – ... Operating result amounted to SEK -16.4 (-6.4) million ... -0.27 per share (-0.22) before and after dilution Cash flow ... ... amounted to SEK 0.4 (0.4) million Operating result amounted to ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... Forecast to 2025" report to their offering. ... The Global Wireless Health Market ... the next decade to reach approximately $330.5 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:2/24/2017)... and Markets has announced the addition of the "Dry eye Drugs ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... following questions: What are the key drugs ... in the Global Dry eye market? What are the ...
Breaking Medicine Technology: